LONDON and CAMBRIDGE, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a ...
"Over the past five years we have built a compelling body of safety and efficacy data on laru-zova across three different clinical studies,” said Lance Baldo, M.D., Chief Executive Officer of Beacon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results